Maximus, Inc. (MMS) 10-Year Financial Performance & Capital Metrics

MMS • • Industrial / General

IndustrialsBusiness ServicesSpecialized Business Process OutsourcingGovernment & Healthcare BPO

AboutMaximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Tysons, Virginia.Show more

Revenue $5.43B +2.4%
EBITDA $723M +15.2%
Net Income $319M +3.9%
EPS (Diluted) 5.51 +10.4%
Gross Margin 23.01% +5.3%
EBITDA Margin 13.3% +12.6%
Operating Margin 10.62% +14.6%
Net Margin 5.87% +1.6%
ROE 18.14% +3.8%
ROIC 15.07% +19.7%
Debt/Equity 0.86 +24.5%
Interest Coverage 6.86 +15.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9
✓High quality earnings: Operating CF exceeds net income
✓Good 3Y average ROE of 15.2%
✓Share count reduced 5.8% through buybacks
✓Trading near 52-week high
✓Efficient asset utilization: 1.3x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.97%

5Y9.43%

3Y5.46%

TTM2.36%

Profit (Net Income) CAGR

10Y7.3%

5Y8.26%

3Y16.11%

TTM3.95%

EPS CAGR

10Y8.9%

5Y10.2%

3Y18.75%

TTM11.2%

ROCE

10Y Avg20.1%

5Y Avg13.69%

3Y Avg13.82%

Latest17.4%

Peer Comparison

Government & Healthcare BPO

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
MMSMaximus, Inc.	5.36B	98.42	17.86	2.36%	5.87%	19.06%	6.83%	0.86
DLHCDLH Holdings Corp.	84.35M	5.82	11.41	5.34%	1.27%	4.03%	31.45%	1.50

Profit & Loss

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales/Revenue+	2.4B	2.45B	2.39B	2.89B	3.46B	4.25B	4.63B	4.9B	5.31B	5.43B
Revenue Growth %	0.14%	0.02%	-0.02%	0.21%	0.2%	0.23%	0.09%	0.06%	0.08%	0.02%
Cost of Goods Sold+	1.85B	1.85B	1.81B	2.29B	2.79B	3.35B	3.78B	3.97B	4.15B	4.19B
COGS % of Revenue	0.77%	0.76%	0.76%	0.79%	0.8%	0.79%	0.82%	0.81%	0.78%	0.77%
Gross Profit+	548.81M	599.7M	584.08M	592.93M	675.37M	902.62M	849.35M	934.02M	1.16B	1.25B
Gross Margin %	0.23%	0.24%	0.24%	0.21%	0.2%	0.21%	0.18%	0.19%	0.22%	0.23%
Gross Profit Growth %	0.09%	0.09%	-0.03%	0.02%	0.14%	0.34%	-0.06%	0.1%	0.24%	0.08%
Operating Expenses+	266.06M	284.51M	284.29M	273.12M	384.19M	483.27M	537.56M	638.65M	668.37M	673.13M
OpEx % of Revenue	0.11%	0.12%	0.12%	0.09%	0.11%	0.11%	0.12%	0.13%	0.13%	0.12%
Selling, General & Admin	266.06M	284.51M	284.29M	273.12M	384.19M	483.27M	537.56M	638.65M	668.37M	673.13M
SG&A % of Revenue	0.11%	0.12%	0.12%	0.09%	0.11%	0.11%	0.12%	0.13%	0.13%	0.12%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	282.75M	315.19M	299.78M	319.81M	291.18M	419.35M	311.78M	295.37M	491.72M	576.75M
Operating Margin %	0.12%	0.13%	0.13%	0.11%	0.08%	0.1%	0.07%	0.06%	0.09%	0.11%
Operating Income Growth %	0.07%	0.11%	-0.05%	0.07%	-0.09%	0.44%	-0.26%	-0.05%	0.66%	0.17%
EBITDA+	354.54M	383.16M	361.98M	405.26M	398.14M	523.67M	453.48M	457.38M	627.04M	722.57M
EBITDA Margin %	0.15%	0.16%	0.15%	0.14%	0.12%	0.12%	0.1%	0.09%	0.12%	0.13%
EBITDA Growth %	0.11%	0.08%	-0.06%	0.12%	-0.02%	0.32%	-0.13%	0.01%	0.37%	0.15%
D&A (Non-Cash Add-back)	71.78M	67.98M	62.19M	85.46M	106.96M	104.32M	141.69M	162.02M	135.33M	145.82M
EBIT	290.1M	316.4M	300.21M	320.28M	289.12M	398.43M	323.06M	294.43M	488.95M	528.93M
Net Interest Income+	-4.13M	-2.16M	-1M	-2.96M	-2.06M	-14.74M	-45.97M	-84.14M	-82.44M	-84.08M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	4.13M	2.16M	1M	2.96M	2.06M	14.74M	45.97M	84.14M	82.44M	84.08M
Other Income/Expense	3.21M	-952K	-574K	-2.49M	-4.12M	-35.67M	-34.69M	-85.08M	-85.21M	-131.9M
Pretax Income+	285.97M	314.24M	299.21M	317.32M	287.06M	383.68M	277.1M	210.29M	406.51M	444.85M
Pretax Margin %	0.12%	0.13%	0.13%	0.11%	0.08%	0.09%	0.06%	0.04%	0.08%	0.08%
Income Tax+	105.81M	102.05M	78.39M	76.83M	72.55M	92.48M	73.27M	48.5M	99.59M	125.81M
Effective Tax Rate %	0.62%	0.67%	0.74%	0.76%	0.75%	0.76%	0.74%	0.77%	0.75%	0.72%
Net Income+	178.36M	209.43M	220.75M	240.82M	214.51M	291.2M	203.83M	161.79M	306.91M	319.03M
Net Margin %	0.07%	0.09%	0.09%	0.08%	0.06%	0.07%	0.04%	0.03%	0.06%	0.06%
Net Income Growth %	0.13%	0.17%	0.05%	0.09%	-0.11%	0.36%	-0.3%	-0.21%	0.9%	0.04%
Net Income (Continuing)	180.16M	212.18M	220.82M	240.5M	214.51M	291.2M	203.83M	161.79M	306.91M	319.03M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	4.06M	5.68M	2.55M	409K	0	0	0	0	0	0
EPS (Diluted)+	2.69	3.17	3.35	3.72	3.39	4.67	3.29	2.63	4.99	5.51
EPS Growth %	0.14%	0.18%	0.06%	0.11%	-0.09%	0.38%	-0.3%	-0.2%	0.9%	0.1%
EPS (Basic)	2.71	3.19	3.37	3.73	3.40	4.69	3.30	2.65	5.03	5.56
Diluted Shares Outstanding	66.23M	66.06M	65.93M	64.82M	63.32M	62.37M	61.97M	61.45M	61.48M	57.92M
Basic Shares Outstanding	65.82M	65.63M	65.5M	64.5M	63.06M	62.07M	61.77M	61.13M	61.05M	57.41M
Dividend Payout Ratio	0.07%	0.06%	0.05%	0.27%	0.33%	0.24%	0.34%	0.42%	0.24%	0.22%

Balance Sheet

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Current Assets+	620.98M	657.24M	808.63M	789.42M	932.56M	1.08B	1.03B	1.06B	1.2B	1.25B
Cash & Short-Term Investments	80.3M	179.75M	376.81M	116.49M	88.56M	156.57M	136.79M	122.09M	235.76M	260.46M
Cash Only	80.3M	179.75M	356.55M	116.49M	88.56M	156.57M	136.79M	122.09M	235.76M	260.46M
Short-Term Investments	0	0	20.26M	0	0	0	0	0	0	0
Accounts Receivable	498.06M	435.34M	395.13M	621.38M	788.28M	840.23M	809.27M	843.43M	884.8M	902M
Days Sales Outstanding	75.64	64.83	60.29	78.57	83.12	72.08	63.78	62.77	60.86	60.62
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	42.62M	42.15M	36.7M	51.55M	55.72M	82.69M	86.25M	89.95M	79.98M	90.47M
Total Non-Current Assets+	727.84M	693.42M	653.37M	956.31M	1.09B	3.04B	2.96B	2.93B	2.93B	2.82B
Property, Plant & Equipment	131.57M	101.65M	77.54M	99.59M	243.88M	241.98M	185.14M	202.76M	172.57M	131.49M
Fixed Asset Turnover	18.27x	24.11x	30.85x	28.99x	14.19x	17.58x	25.01x	24.19x	30.75x	41.31x
Goodwill	397.56M	402.98M	399.88M	584.47M	593.13M	1.77B	1.78B	1.78B	1.78B	1.78B
Intangible Assets	139.17M	125.52M	110.46M	211.62M	183.93M	922.04M	863.64M	811.46M	818.25M	752.53M
Long-Term Investments	0	0	0	0	0	0	31.4M	31.4M	12.6M	5.5M
Other Non-Current Assets	50.9M	55.59M	58.64M	60.44M	69.29M	100.06M	95.83M	103.04M	129.88M	133.62M
Total Assets+	1.35B	1.35B	1.46B	1.75B	2.02B	4.12B	3.99B	3.99B	4.13B	4.07B
Asset Turnover	1.78x	1.81x	1.64x	1.65x	1.71x	1.03x	1.16x	1.23x	1.28x	1.33x
Asset Growth %	0.05%	0%	0.08%	0.19%	0.16%	1.03%	-0.03%	-0%	0.04%	-0.01%
Total Current Liabilities+	340.76M	316.27M	277.45M	364.24M	561.17M	789.43M	774.45M	723.01M	807.53M	765.16M
Accounts Payable	150.71M	122.08M	114.38M	177.79M	253.34M	305.56M	264.55M	282.08M	303.32M	296.89M
Days Payables Outstanding	29.66	24.07	23.09	28.29	33.19	33.27	25.53	25.93	26.7	25.86
Short-Term Debt	277K	141K	0	9.66M	91.63M	156.63M	127.46M	136.7M	87.8M	91.28M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	11.62M	11.95M	11.9M	12.71M	22.07M	35.06M	116.37M	49.06M	69.52M	68.94M
Current Ratio	1.82x	2.08x	2.91x	2.17x	1.66x	1.37x	1.33x	1.46x	1.49x	1.64x
Quick Ratio	1.82x	2.08x	2.91x	2.17x	1.66x	1.37x	1.33x	1.46x	1.49x	1.64x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	254.92M	88.63M	98.13M	133.29M	221.72M	1.85B	1.67B	1.59B	1.48B	1.63B
Long-Term Debt	165.34M	527K	0	231K	18.02M	1.43B	1.29B	1.16B	1.09B	1.28B
Capital Lease Obligations	0	0	0	0	104.01M	121.77M	86.17M	129.37M	97.22M	71.29M
Deferred Tax Liabilities	16.81M	20.11M	26.38M	46.56M	24.74M	194.64M	206.1M	203.9M	169.12M	149.02M
Other Non-Current Liabilities	32.77M	39.81M	51.36M	54.39M	47.64M	67.72M	62.72M	59.68M	77.79M	84.78M
Total Liabilities	595.68M	404.89M	375.58M	497.53M	782.88M	2.64B	2.44B	2.32B	2.29B	2.4B
Total Debt+	165.62M	668K	136K	9.89M	213.65M	1.71B	1.51B	1.43B	1.28B	1.44B
Net Debt	85.32M	-179.08M	-356.55M	-106.83M	125.09M	1.55B	1.37B	1.31B	1.04B	1.18B
Debt / Equity	0.22x	0.00x	0.00x	0.01x	0.17x	1.15x	0.97x	0.86x	0.69x	0.86x
Debt / EBITDA	0.47x	0.00x	0.00x	0.02x	0.54x	3.26x	3.32x	3.12x	2.04x	2.00x
Net Debt / EBITDA	0.24x	-0.47x	-0.98x	-0.26x	0.31x	2.96x	3.02x	2.86x	1.66x	1.64x
Interest Coverage	68.40x	145.78x	299.78x	108.15x	141.42x	28.44x	6.78x	3.51x	5.96x	6.86x
Total Equity+	753.14M	945.77M	1.09B	1.25B	1.24B	1.48B	1.55B	1.67B	1.84B	1.67B
Equity Growth %	0.22%	0.26%	0.15%	0.15%	-0.01%	0.19%	0.05%	0.08%	0.1%	-0.09%
Book Value per Share	11.37	14.32	16.48	19.26	19.61	23.74	25.00	27.14	29.97	28.90
Total Shareholders' Equity	749.08M	940.09M	1.08B	1.25B	1.24B	1.48B	1.55B	1.67B	1.84B	1.67B
Common Stock	461.68M	475.59M	487.54M	498.43M	513.96M	532.41M	557.98M	577.9M	598.3M	628.12M
Retained Earnings	323.57M	492.11M	633.28M	794.74M	770.5M	987.83M	1.03B	1.12B	1.28B	1.06B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-36.17M	-27.62M	-36.95M	-45.38M	-42.64M	-39.91M	-33.96M	-27.61M	-32.46M	-17.87M
Minority Interest	4.06M	5.68M	2.55M	409K	0	0	0	0	0	0

Cash Flow

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Cash from Operations+	180.03M	337.2M	323.52M	356.73M	244.59M	517.32M	289.84M	314.34M	515.26M	429.37M
Operating CF Margin %	0.07%	0.14%	0.14%	0.12%	0.07%	0.12%	0.06%	0.06%	0.1%	0.08%
Operating CF Growth %	-0.13%	0.87%	-0.04%	0.1%	-0.31%	1.12%	-0.44%	0.08%	0.64%	-0.17%
Net Income	180.16M	212.18M	220.82M	240.5M	214.51M	291.2M	203.83M	161.79M	306.91M	319.03M
Depreciation & Amortization	71.78M	67.98M	62.19M	85.46M	100.16M	90.72M	132.79M	149.32M	125.53M	133.72M
Stock-Based Compensation	18.75M	21.36M	20.24M	20.77M	23.71M	28.55M	30.48M	29.52M	35.35M	41.18M
Deferred Taxes	5.65M	4.76M	6.72M	12.66M	-19.14M	-6.58M	10.2M	1.55M	-36.02M	-16.72M
Other Non-Cash Items	-6.88M	-650K	113.46M	0	-1.72M	9.37M	-8.03M	3.72M	4.55M	42.33M
Working Capital Changes	-89.44M	31.56M	13.56M	-2.66M	-72.92M	104.05M	-79.43M	-31.56M	78.94M	-90.17M
Change in Receivables	-51.99M	53.02M	34.03M	-60.31M	-141.84M	38.58M	14.13M	-23.4M	-50.56M	-31.85M
Change in Inventory	-7.62M	2.61M	9.87M	-47.58M	-79.93M	-26.9M	0	859K	0	0
Change in Payables	-2.37M	-28.31M	-7.72M	47.58M	79.93M	26.9M	-32.72M	17.73M	18.27M	-7.49M
Cash from Investing+	-87.1M	-25.22M	-46.3M	-483.88M	-44.14M	-1.84B	-54.01M	-80.96M	-129.1M	-60.26M
Capital Expenditures	-46.39M	-24.15M	-26.52M	-66.85M	-40.71M	-36.56M	-56.15M	-90.69M	-114.19M	-63.21M
CapEx % of Revenue	0.02%	0.01%	0.01%	0.02%	0.01%	0.01%	0.01%	0.02%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	424K	575K	369K	20.45M	385K	0	16.43M	0	-18M	2.95M
Cash from Financing+	-96.84M	-215.43M	-91.88M	-110.86M	-230.09M	1.39B	-248.27M	-250.8M	-275.65M	-343.88M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-11.7M	-11.67M	-11.69M	-63.89M	-70.16M	-68.84M	-68.72M	-68.07M	-72.9M	-68.71M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-6.97M	-10.84M	-13.13M	-9.05M	-11.58M	-35.75M	72.22M	-65.58M	-17.64M	-27.39M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	133.63M	313.05M	297M	289.88M	203.88M	480.76M	233.69M	223.65M	401.07M	366.16M
FCF Margin %	0.06%	0.13%	0.12%	0.1%	0.06%	0.11%	0.05%	0.05%	0.08%	0.07%
FCF Growth %	0.32%	1.34%	-0.05%	-0.02%	-0.3%	1.36%	-0.51%	-0.04%	0.79%	-0.09%
FCF per Share	2.02	4.74	4.50	4.47	3.22	7.71	3.77	3.64	6.52	6.32
FCF Conversion (FCF/Net Income)	1.01x	1.61x	1.47x	1.48x	1.14x	1.78x	1.42x	1.94x	1.68x	1.35x
Interest Paid	0	0	0	0	0	14.54M	43.09M	81.1M	78.95M	0
Taxes Paid	0	0	0	0	0	99.9M	76.04M	61.05M	99.69M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	26.01%	24.65%	21.73%	20.63%	17.23%	21.39%	13.46%	10.06%	17.48%	18.14%
Return on Invested Capital (ROIC)	26.85%	29.45%	30.04%	25.63%	17.41%	14.3%	7.86%	7.52%	12.59%	15.07%
Gross Margin	22.84%	24.47%	24.42%	20.54%	19.51%	21.22%	18.34%	19.04%	21.86%	23.01%
Net Margin	7.42%	8.54%	9.23%	8.34%	6.2%	6.84%	4.4%	3.3%	5.78%	5.87%
Debt / Equity	0.22x	0.00x	0.00x	0.01x	0.17x	1.15x	0.97x	0.86x	0.69x	0.86x
Interest Coverage	68.40x	145.78x	299.78x	108.15x	141.42x	28.44x	6.78x	3.51x	5.96x	6.86x
FCF Conversion	1.01x	1.61x	1.47x	1.48x	1.14x	1.78x	1.42x	1.94x	1.68x	1.35x
Revenue Growth	14.46%	1.98%	-2.4%	20.67%	19.91%	22.91%	8.85%	5.91%	8.19%	2.36%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Clinical Services	-	-	-	-	-	-	-	-	-	2.1B
Clinical Services Growth	-	-	-	-	-	-	-	-	-	-
Advanced Technology Solutions	-	-	-	-	-	-	-	-	-	324.73M
Advanced Technology Solutions Growth	-	-	-	-	-	-	-	-	-	-
U.S. Federal Services	591.73M	545.57M	478.91M	1.11B	1.63B	1.89B	2.26B	2.4B	2.74B	-
U.S. Federal Services Growth	-	-7.80%	-12.22%	132.03%	46.99%	15.92%	19.36%	6.37%	13.88%	-
US Services	-	-	-	-	-	1.66B	1.61B	1.81B	1.91B	-
US Services Growth	-	-	-	-	-	-	-3.28%	12.72%	5.50%	-
Outside The United States	-	-	-	-	-	699.09M	763.66M	689.05M	657.14M	-
Outside The United States Growth	-	-	-	-	-	-	9.24%	-9.77%	-4.63%	-
U.S. Services	-	-	-	-	1.33B	-	-	-	-	-
U.S. Services Growth	-	-	-	-	-	-	-	-	-	-
Outside the U.S.	-	-	-	599.13M	498.93M	-	-	-	-	-
Outside the U.S. Growth	-	-	-	-	-16.72%	-	-	-	-	-
U.S. Health and Human Services	-	-	-	1.18B	-	-	-	-	-	-
U.S. Health and Human Services Growth	-	-	-	-	-	-	-	-	-	-
Health Services	1.3B	1.38B	1.4B	-	-	-	-	-	-	-
Health Services Growth	-	6.30%	1.80%	-	-	-	-	-	-	-
Human Services	513.33M	525.24M	508.37M	-	-	-	-	-	-	-
Human Services Growth	-	2.32%	-3.21%	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
UNITED STATES	1.72B	1.77B	1.69B	2.29B	2.96B	3.56B	3.87B	-	-	-
UNITED STATES Growth	-	2.58%	-4.13%	35.14%	29.50%	20.01%	8.77%	-	-	-
UNITED KINGDOM	-	-	-	293.69M	246.34M	286.43M	410.59M	-	-	-
UNITED KINGDOM Growth	-	-	-	-	-16.13%	16.28%	43.35%	-	-	-
World	96.91M	106.52M	104.54M	106.64M	105.44M	167.66M	180M	-	-	-
World Growth	-	9.92%	-1.87%	2.01%	-1.13%	59.02%	7.36%	-	-	-
AUSTRALIA	200.54M	232.43M	247.85M	198.79M	147.16M	245M	173.08M	-	-	-
AUSTRALIA Growth	-	15.90%	6.63%	-19.79%	-25.98%	66.49%	-29.35%	-	-	-

Frequently Asked Questions

Valuation & Price

Maximus, Inc. (MMS) has a price-to-earnings (P/E) ratio of 17.9x. This is roughly in line with market averages.

Growth & Financials

Maximus, Inc. (MMS) reported $5.43B in revenue for fiscal year 2025. This represents a 417% increase from $1.05B in 2012.

Maximus, Inc. (MMS) grew revenue by 2.4% over the past year. Growth has been modest.

Yes, Maximus, Inc. (MMS) is profitable, generating $319.0M in net income for fiscal year 2025 (5.9% net margin).

Dividend & Returns

Yes, Maximus, Inc. (MMS) pays a dividend with a yield of 1.21%. This makes it attractive for income-focused investors.

Maximus, Inc. (MMS) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.

Maximus, Inc. (MMS) generated $366.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...